| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Quantitative Structure-Activity Relationship | 6 | 2021 | 209 | 0.88 | Why? |
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2017 | 15 | 0.70 | Why? |
| Positive-Pressure Respiration | 8 | 2017 | 1160 | 0.54 | Why? |
| Sepsis | 5 | 2018 | 3517 | 0.54 | Why? |
| Palliative Care | 3 | 2017 | 2665 | 0.53 | Why? |
| Death | 1 | 2017 | 334 | 0.52 | Why? |
| Hypotension | 1 | 2017 | 392 | 0.52 | Why? |
| Organ Dysfunction Scores | 2 | 2020 | 1475 | 0.49 | Why? |
| Randomized Controlled Trials as Topic | 14 | 2020 | 10649 | 0.42 | Why? |
| Shock | 2 | 2020 | 1868 | 0.42 | Why? |
| Infant, Newborn, Diseases | 1 | 2014 | 394 | 0.42 | Why? |
| Intensive Care Units | 12 | 2020 | 29594 | 0.42 | Why? |
| Continuity of Patient Care | 2 | 2018 | 1574 | 0.41 | Why? |
| Nitric Oxide | 1 | 2017 | 769 | 0.40 | Why? |
| High-Frequency Ventilation | 3 | 2017 | 57 | 0.38 | Why? |
| Delirium | 1 | 2019 | 1061 | 0.38 | Why? |
| Electronic Mail | 1 | 2009 | 102 | 0.37 | Why? |
| Ethylamines | 2 | 2018 | 7 | 0.37 | Why? |
| Critical Care | 7 | 2019 | 14081 | 0.37 | Why? |
| Hemorrhagic Fever, Ebola | 4 | 2019 | 1475 | 0.33 | Why? |
| Respiratory Insufficiency | 5 | 2020 | 7301 | 0.30 | Why? |
| Noninvasive Ventilation | 2 | 2018 | 2329 | 0.29 | Why? |
| Evidence-Based Medicine | 4 | 2020 | 3228 | 0.29 | Why? |
| Protease Inhibitors | 1 | 2021 | 3630 | 0.28 | Why? |
| Acute Kidney Injury | 4 | 2018 | 5762 | 0.28 | Why? |
| HIV Protease Inhibitors | 2 | 2018 | 434 | 0.27 | Why? |
| Ventilator-Induced Lung Injury | 5 | 2017 | 260 | 0.24 | Why? |
| Airway Extubation | 2 | 2018 | 403 | 0.24 | Why? |
| Drug Design | 5 | 2021 | 2627 | 0.23 | Why? |
| Cell Phone | 1 | 2009 | 750 | 0.23 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.23 | Why? |
| Interprofessional Relations | 1 | 2009 | 1013 | 0.23 | Why? |
| Drug Resistance, Multiple | 2 | 2019 | 156 | 0.21 | Why? |
| Models, Organizational | 1 | 2006 | 908 | 0.20 | Why? |
| beta-Lactamases | 2 | 2018 | 759 | 0.20 | Why? |
| Proxy | 1 | 2019 | 32 | 0.20 | Why? |
| Respiration, Artificial | 8 | 2020 | 22116 | 0.20 | Why? |
| Critical Illness | 9 | 2020 | 17281 | 0.20 | Why? |
| Hydroxamic Acids | 1 | 2019 | 43 | 0.20 | Why? |
| Models, Molecular | 5 | 2021 | 7616 | 0.19 | Why? |
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2019 | 45 | 0.19 | Why? |
| Matrix Metalloproteinase Inhibitors | 1 | 2017 | 45 | 0.18 | Why? |
| Glutamic Acid | 1 | 2017 | 65 | 0.18 | Why? |
| Therapeutic Equipoise | 1 | 2017 | 52 | 0.17 | Why? |
| Ventilator Weaning | 2 | 2017 | 536 | 0.17 | Why? |
| Tidal Volume | 5 | 2017 | 565 | 0.17 | Why? |
| Respiratory Muscles | 1 | 2018 | 116 | 0.17 | Why? |
| Nepal | 3 | 2018 | 1004 | 0.16 | Why? |
| Anti-Bacterial Agents | 3 | 2018 | 10083 | 0.16 | Why? |
| Airway Obstruction | 1 | 2019 | 182 | 0.16 | Why? |
| Patient Care Team | 2 | 2018 | 3556 | 0.16 | Why? |
| Tetrazoles | 1 | 2019 | 262 | 0.16 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2014 | 1115 | 0.16 | Why? |
| Insufflation | 1 | 2016 | 61 | 0.16 | Why? |
| Intubation | 1 | 2018 | 437 | 0.15 | Why? |
| Antiviral Agents | 4 | 2021 | 41703 | 0.15 | Why? |
| Urine | 1 | 2018 | 469 | 0.14 | Why? |
| Drug Discovery | 2 | 2021 | 3092 | 0.14 | Why? |
| Peritoneal Dialysis | 1 | 2021 | 498 | 0.14 | Why? |
| Cerebrovascular Circulation | 1 | 2018 | 340 | 0.14 | Why? |
| Ebolavirus | 2 | 2019 | 834 | 0.14 | Why? |
| Goals | 1 | 2017 | 335 | 0.14 | Why? |
| Humans | 54 | 2021 | 930598 | 0.13 | Why? |
| Hospitals, Maternity | 1 | 2014 | 154 | 0.13 | Why? |
| Neoplasm Proteins | 1 | 2019 | 501 | 0.13 | Why? |
| Intubation, Intratracheal | 3 | 2019 | 3962 | 0.13 | Why? |
| Health Resources | 2 | 2017 | 2592 | 0.13 | Why? |
| Chemoprevention | 1 | 2018 | 585 | 0.13 | Why? |
| Oxygen Consumption | 2 | 2018 | 711 | 0.13 | Why? |
| Penicillins | 1 | 2014 | 132 | 0.13 | Why? |
| Infant, Low Birth Weight | 1 | 2014 | 243 | 0.13 | Why? |
| Disease Management | 4 | 2019 | 6841 | 0.13 | Why? |
| Endocarditis | 1 | 2018 | 368 | 0.13 | Why? |
| Vitamins | 2 | 2021 | 1208 | 0.12 | Why? |
| Hypoxia | 2 | 2017 | 3626 | 0.12 | Why? |
| Ascorbic Acid | 1 | 2018 | 676 | 0.12 | Why? |
| Ontario | 3 | 2018 | 1966 | 0.12 | Why? |
| Prone Position | 3 | 2017 | 1861 | 0.11 | Why? |
| Resuscitation | 1 | 2017 | 638 | 0.11 | Why? |
| Developing Countries | 2 | 2018 | 4283 | 0.11 | Why? |
| Pressure Ulcer | 1 | 2017 | 398 | 0.11 | Why? |
| Pulmonary Medicine | 1 | 2017 | 706 | 0.11 | Why? |
| Hyperglycemia | 1 | 2021 | 1363 | 0.10 | Why? |
| Sulfonamides | 1 | 2019 | 1294 | 0.10 | Why? |
| Medical Records | 2 | 2018 | 513 | 0.10 | Why? |
| Hydrocortisone | 1 | 2020 | 1790 | 0.10 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.10 | Why? |
| Multiple Organ Failure | 2 | 2018 | 1724 | 0.10 | Why? |
| Gram-Negative Bacteria | 1 | 2014 | 473 | 0.10 | Why? |
| Decision Making | 2 | 2019 | 3132 | 0.10 | Why? |
| Research Design | 1 | 2006 | 5830 | 0.10 | Why? |
| Infant, Premature | 1 | 2014 | 883 | 0.10 | Why? |
| Physical Therapy Modalities | 1 | 2018 | 1090 | 0.10 | Why? |
| Quality Improvement | 2 | 2019 | 2435 | 0.10 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2018 | 1731 | 0.09 | Why? |
| Health Care Costs | 1 | 2017 | 1007 | 0.09 | Why? |
| Antioxidants | 1 | 2018 | 1593 | 0.09 | Why? |
| Ventilators, Mechanical | 1 | 2020 | 2193 | 0.09 | Why? |
| Length of Stay | 4 | 2019 | 11042 | 0.09 | Why? |
| Renal Replacement Therapy | 2 | 2018 | 1530 | 0.09 | Why? |
| Aerosols | 2 | 2021 | 5393 | 0.09 | Why? |
| Personnel Staffing and Scheduling | 1 | 2017 | 1578 | 0.08 | Why? |
| Shock, Septic | 1 | 2017 | 1313 | 0.08 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.08 | Why? |
| Africa, Western | 2 | 2018 | 363 | 0.08 | Why? |
| Caregivers | 2 | 2019 | 3112 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Adrenal Cortex Hormones | 2 | 2020 | 6537 | 0.08 | Why? |
| Poverty | 1 | 2018 | 2302 | 0.08 | Why? |
| Severity of Illness Index | 6 | 2020 | 48226 | 0.08 | Why? |
| Health Care Rationing | 1 | 2020 | 2558 | 0.08 | Why? |
| Databases, Bibliographic | 1 | 2006 | 182 | 0.07 | Why? |
| Judgment | 1 | 2006 | 98 | 0.07 | Why? |
| Efficiency, Organizational | 1 | 2009 | 482 | 0.07 | Why? |
| Risk | 1 | 2018 | 5288 | 0.07 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Depression | 2 | 2019 | 14116 | 0.06 | Why? |
| Canada | 4 | 2019 | 6018 | 0.06 | Why? |
| Pregnancy Complications | 1 | 2014 | 1388 | 0.06 | Why? |
| Models, Educational | 1 | 2006 | 289 | 0.06 | Why? |
| Practice Guidelines as Topic | 4 | 2020 | 15421 | 0.06 | Why? |
| Adult | 16 | 2020 | 244371 | 0.06 | Why? |
| Patient Discharge | 1 | 2019 | 5696 | 0.06 | Why? |
| Review Literature as Topic | 1 | 2006 | 387 | 0.06 | Why? |
| Consumer Behavior | 1 | 2009 | 544 | 0.06 | Why? |
| Linear Models | 2 | 2019 | 1914 | 0.06 | Why? |
| Cough | 1 | 2016 | 4891 | 0.06 | Why? |
| Diffusion of Innovation | 1 | 2006 | 440 | 0.06 | Why? |
| Data Interpretation, Statistical | 1 | 2006 | 657 | 0.06 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.06 | Why? |
| Fever | 2 | 2019 | 7795 | 0.06 | Why? |
| Patient Admission | 1 | 2018 | 5250 | 0.06 | Why? |
| Hospital Mortality | 4 | 2019 | 22087 | 0.06 | Why? |
| Disease Outbreaks | 3 | 2019 | 27595 | 0.06 | Why? |
| Triage | 1 | 2020 | 7151 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.06 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.05 | Why? |
| Brain | 1 | 2018 | 5133 | 0.05 | Why? |
| Education, Medical | 1 | 2017 | 2461 | 0.05 | Why? |
| Information Storage and Retrieval | 1 | 2006 | 644 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.05 | Why? |
| Biomedical Research | 2 | 2017 | 5270 | 0.05 | Why? |
| Jaw | 1 | 2019 | 9 | 0.05 | Why? |
| Venous Thromboembolism | 1 | 2018 | 4273 | 0.05 | Why? |
| Amodiaquine | 1 | 2019 | 57 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Meta-Analysis as Topic | 1 | 2006 | 1289 | 0.05 | Why? |
| Health Facility Size | 1 | 2018 | 37 | 0.05 | Why? |
| Spin Labels | 1 | 2018 | 36 | 0.05 | Why? |
| Bayes Theorem | 2 | 2019 | 3237 | 0.05 | Why? |
| Disk Diffusion Antimicrobial Tests | 1 | 2018 | 36 | 0.05 | Why? |
| Patient Acceptance of Health Care | 1 | 2017 | 5002 | 0.05 | Why? |
| Least-Squares Analysis | 1 | 2019 | 254 | 0.05 | Why? |
| Male | 15 | 2021 | 367725 | 0.04 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.04 | Why? |
| Models, Theoretical | 1 | 2017 | 6659 | 0.04 | Why? |
| Chest Wall Oscillation | 1 | 2017 | 17 | 0.04 | Why? |
| Matrix Metalloproteinase 2 | 1 | 2017 | 85 | 0.04 | Why? |
| Prospective Studies | 4 | 2017 | 43301 | 0.04 | Why? |
| Early Termination of Clinical Trials | 1 | 2020 | 1256 | 0.04 | Why? |
| Motor Activity | 1 | 2019 | 217 | 0.04 | Why? |
| Risk Factors | 5 | 2019 | 71621 | 0.04 | Why? |
| Health Policy | 1 | 2017 | 6242 | 0.04 | Why? |
| Deep Sedation | 1 | 2018 | 121 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2019 | 640 | 0.04 | Why? |
| Female | 14 | 2020 | 380317 | 0.04 | Why? |
| Infant, Newborn | 2 | 2017 | 23105 | 0.04 | Why? |
| Artemisinins | 1 | 2019 | 238 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Neuromuscular Blocking Agents | 1 | 2017 | 121 | 0.04 | Why? |
| Data Collection | 1 | 2006 | 1769 | 0.04 | Why? |
| Likelihood Functions | 1 | 2019 | 719 | 0.04 | Why? |
| Lung Compliance | 1 | 2017 | 243 | 0.04 | Why? |
| Nervous System | 1 | 2018 | 303 | 0.04 | Why? |
| Prognosis | 2 | 2017 | 32490 | 0.04 | Why? |
| Drug Resistance, Neoplasm | 1 | 2019 | 447 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Middle Aged | 12 | 2020 | 270681 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.04 | Why? |
| Pulmonary Ventilation | 1 | 2016 | 152 | 0.04 | Why? |
| Monte Carlo Method | 1 | 2017 | 577 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Cannula | 1 | 2020 | 750 | 0.03 | Why? |
| Aged | 10 | 2021 | 215776 | 0.03 | Why? |
| Drug Resistance | 1 | 2017 | 395 | 0.03 | Why? |
| Blood Gas Analysis | 1 | 2017 | 893 | 0.03 | Why? |
| Mouth | 1 | 2019 | 622 | 0.03 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.03 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.03 | Why? |
| Cohort Studies | 3 | 2019 | 36005 | 0.03 | Why? |
| Hospitalization | 3 | 2019 | 54280 | 0.03 | Why? |
| Global Burden of Disease | 1 | 2017 | 531 | 0.03 | Why? |
| New York | 1 | 2020 | 2488 | 0.03 | Why? |
| Oropharynx | 1 | 2021 | 1581 | 0.03 | Why? |
| Pregnancy | 1 | 2014 | 23879 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Lung | 2 | 2017 | 31049 | 0.03 | Why? |
| Child | 2 | 2018 | 70012 | 0.03 | Why? |
| Dogs | 1 | 2019 | 2529 | 0.03 | Why? |
| Patient Selection | 1 | 2006 | 4560 | 0.03 | Why? |
| Renal Dialysis | 2 | 2018 | 4358 | 0.03 | Why? |
| Pharynx | 1 | 2019 | 1544 | 0.03 | Why? |
| In Vitro Techniques | 1 | 2014 | 1027 | 0.03 | Why? |
| Clinical Competence | 1 | 2006 | 3263 | 0.03 | Why? |
| Treatment Outcome | 4 | 2020 | 51732 | 0.03 | Why? |
| Logistic Models | 2 | 2017 | 9089 | 0.03 | Why? |
| Neuroimaging | 1 | 2018 | 1106 | 0.03 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.03 | Why? |
| Mutagens | 1 | 1990 | 38 | 0.03 | Why? |
| Plasma | 1 | 2020 | 1809 | 0.02 | Why? |
| Drug Combinations | 1 | 2019 | 3852 | 0.02 | Why? |
| Health Facilities | 1 | 2017 | 1230 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
| Pesticides | 1 | 1990 | 100 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Interviews as Topic | 1 | 2018 | 1952 | 0.02 | Why? |
| Pain Management | 1 | 2017 | 854 | 0.02 | Why? |
| Recovery of Function | 1 | 2019 | 2461 | 0.02 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2017 | 5002 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Internet | 1 | 2006 | 6204 | 0.02 | Why? |
| Pyrazines | 1 | 2019 | 1783 | 0.02 | Why? |
| Amides | 1 | 2019 | 1864 | 0.02 | Why? |
| Plants | 1 | 1990 | 247 | 0.02 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.02 | Why? |
| Hospitals, Pediatric | 1 | 2018 | 1792 | 0.02 | Why? |
| Cross-Sectional Studies | 1 | 2014 | 53120 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.02 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.02 | Why? |
| Diarrhea | 1 | 2019 | 2743 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2017 | 1956 | 0.02 | Why? |
| Qualitative Research | 1 | 2018 | 4337 | 0.02 | Why? |
| Creatinine | 1 | 2012 | 1443 | 0.02 | Why? |
| Time Factors | 3 | 2019 | 31397 | 0.02 | Why? |
| Quality of Health Care | 1 | 2017 | 1948 | 0.02 | Why? |
| Family | 1 | 2019 | 2909 | 0.02 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.02 | Why? |
| International Cooperation | 1 | 2017 | 3436 | 0.02 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2019 | 6902 | 0.02 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2019 | 8495 | 0.01 | Why? |
| Breast Neoplasms | 1 | 2019 | 3633 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2019 | 8041 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2019 | 22971 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.01 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.01 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Comorbidity | 1 | 2018 | 34796 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.01 | Why? |
| Animals | 2 | 2019 | 78931 | 0.01 | Why? |
| Mutagenicity Tests | 1 | 1990 | 13 | 0.01 | Why? |
| Micronucleus Tests | 1 | 1990 | 12 | 0.01 | Why? |
| Histidine | 1 | 1990 | 72 | 0.01 | Why? |
| Chromosome Aberrations | 1 | 1990 | 54 | 0.01 | Why? |
| Salmonella typhimurium | 1 | 1990 | 81 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2016 | 43792 | 0.01 | Why? |
| Bone Marrow Cells | 1 | 1990 | 186 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
| Biological Assay | 1 | 1990 | 367 | 0.01 | Why? |
| Bone Marrow | 1 | 1990 | 492 | 0.00 | Why? |
| Pneumonia | 1 | 2006 | 5652 | 0.00 | Why? |
| Rats | 1 | 1990 | 2764 | 0.00 | Why? |
| Mutation | 1 | 1990 | 12376 | 0.00 | Why? |